Safety and Efficacy of a Randomized Phase I Trial to Evaluate Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients with Stage IV Non-small Cell Lung Cancer (COSINR Study)

Authors :: Sean P. Pitroda
Michael J. Jelinek
A. Pandey
J. Gordon
S.J. Chmura
Christine M. Bestvina
Theodore Karrison
Benjamin E. Onderdonk
Aditya Juloori
J.M. Melotek
Everett E. Vokes
J. Ball
K.B. Pointer
Ralph R. Weichselbaum
Philip C. Hoffman
Jyoti D. Patel
Source :: International Journal of Radiation Oncology*Biology*Physics. 108:S72
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Radiation
business.industry
Ipilimumab
Stage IV non-small cell lung cancer
Internal medicine
medicine
Radiology, Nuclear Medicine and imaging
In patient
Nivolumab
business
Stereotactic body radiotherapy
medicine.drug

Full Text Access

Tools